Bespoke Extracts Inc banner

Bespoke Extracts Inc
OTC:BSPK

Watchlist Manager
Bespoke Extracts Inc Logo
Bespoke Extracts Inc
OTC:BSPK
Watchlist
Price: 0.2524 USD Market Closed
Market Cap: $2.8m

Relative Value

The Relative Value of one BSPK stock under the Base Case scenario is 0.2607 USD. Compared to the current market price of 0.2524 USD, Bespoke Extracts Inc is Undervalued by 3%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BSPK Relative Value
Base Case
0.2607 USD
Undervaluation 3%
Relative Value
Price
Worst Case
Base Case
Best Case

Multiples Across Competitors

BSPK Competitors Multiples
Bespoke Extracts Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Bespoke Extracts Inc
OTC:BSPK
2.8m USD 2.3 -3 -4.9 -5
US
Eli Lilly and Co
NYSE:LLY
986.9B USD 15.1 47.8 32.2 34.4
US
Johnson & Johnson
NYSE:JNJ
596.5B USD 6.3 22.3 15.4 19
CH
Roche Holding AG
SIX:ROG
283.9B CHF 4.6 30.2 12.8 14.9
CH
Novartis AG
SIX:NOVN
247.6B CHF 5.7 22.9 14.1 18.1
UK
AstraZeneca PLC
LSE:AZN
238.1B GBP 5.5 31.3 17.3 24.4
US
Merck & Co Inc
NYSE:MRK
305.9B USD 4.7 16.8 10.4 12.6
IE
Endo International PLC
LSE:0Y5F
218B USD 94 -74.6 344.9 865
DK
Novo Nordisk A/S
CSE:NOVO B
1T DKK 3.4 10.2 7.6 8.9
US
Pfizer Inc
NYSE:PFE
156.9B USD 2.5 20.2 7.7 10.3
US
Bristol-Myers Squibb Co
NYSE:BMY
125.6B USD 2.6 17.8 7.4 9.2
P/E Multiple
Earnings Growth PEG
US
Bespoke Extracts Inc
OTC:BSPK
Average P/E: 24.4
Negative Multiple: -3
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
47.8
28%
1.7
US
Johnson & Johnson
NYSE:JNJ
22.3
7%
3.2
CH
Roche Holding AG
SIX:ROG
30.2
29%
1
CH
Novartis AG
SIX:NOVN
22.9
15%
1.5
UK
AstraZeneca PLC
LSE:AZN
31.3
26%
1.2
US
Merck & Co Inc
NYSE:MRK
16.8
14%
1.2
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -74.6 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
10.2
7%
1.5
US
Pfizer Inc
NYSE:PFE
20.2
26%
0.8
US
Bristol-Myers Squibb Co
NYSE:BMY
17.8
17%
1
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Bespoke Extracts Inc
OTC:BSPK
Average EV/EBITDA: 47
Negative Multiple: -4.9
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
32.2
22%
1.5
US
Johnson & Johnson
NYSE:JNJ
15.4
2%
7.7
CH
Roche Holding AG
SIX:ROG
12.8
5%
2.6
CH
Novartis AG
SIX:NOVN
14.1
5%
2.8
UK
AstraZeneca PLC
LSE:AZN
17.3
13%
1.3
US
Merck & Co Inc
NYSE:MRK
10.4
3%
3.5
IE
E
Endo International PLC
LSE:0Y5F
344.9
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
7.6
2%
3.8
US
Pfizer Inc
NYSE:PFE
7.7
-9%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
7.4
-10%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Bespoke Extracts Inc
OTC:BSPK
Average EV/EBIT: 101.7
Negative Multiple: -5
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
34.4
22%
1.6
US
Johnson & Johnson
NYSE:JNJ
19
7%
2.7
CH
Roche Holding AG
SIX:ROG
14.9
6%
2.5
CH
Novartis AG
SIX:NOVN
18.1
9%
2
UK
AstraZeneca PLC
LSE:AZN
24.4
21%
1.2
US
Merck & Co Inc
NYSE:MRK
12.6
6%
2.1
IE
E
Endo International PLC
LSE:0Y5F
865
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
8.9
3%
3
US
Pfizer Inc
NYSE:PFE
10.3
-4%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
9.2
-7%
N/A
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett